Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer.

Literature DB >> 26380191

Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer.

Jan P van Meerbeeck¹, Halil Sirimsi¹.

Abstract

Entities: Disease Species

Year: 2015 PMID： 26380191 PMCID： PMC4549483 DOI： 10.3978/j.issn.2218-6751.2015.07.06

Source DB: PubMed Journal: Transl Lung Cancer Res ISSN： 2218-6751

× No keyword cloud information.

28 in total

Review 1. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Authors: David G Pfister; David H Johnson; Christopher G Azzoli; William Sause; Thomas J Smith; Sherman Baker; Jemi Olak; Diane Stover; John R Strawn; Andrew T Turrisi; Mark R Somerfield
Journal: J Clin Oncol Date: 2003-12-22 Impact factor: 44.544

Review 2. Adjuvant chemotherapy in completely resected non-small-cell lung cancer.

Authors: Katherine M W Pisters; Thierry Le Chevalier
Journal: J Clin Oncol Date: 2005-05-10 Impact factor: 44.544

3. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

Authors: Rebecca M Lindell; Thomas E Hartman; Stephen J Swensen; James R Jett; David E Midthun; Henry D Tazelaar; Jayawant N Mandrekar
Journal: Radiology Date: 2007-02 Impact factor: 11.105

4. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Authors: J Vansteenkiste; L Crinò; C Dooms; J Y Douillard; C Faivre-Finn; E Lim; G Rocco; S Senan; P Van Schil; G Veronesi; R Stahel; S Peters; E Felip
Journal: Ann Oncol Date: 2014-02-20 Impact factor: 32.976

5. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.

Authors: Masatsugu Hamaji; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Francis C Nichols; Dennis A Wigle; K Robert Shen
Journal: J Thorac Cardiovasc Surg Date: 2013-03 Impact factor: 5.209

6. Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors: William C Black; Ilana F Gareen; Samir S Soneji; JoRean D Sicks; Emmett B Keeler; Denise R Aberle; Arash Naeim; Timothy R Church; Gerard A Silvestri; Jeremy Gorelick; Constantine Gatsonis
Journal: N Engl J Med Date: 2014-11-06 Impact factor: 91.245

7. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors: Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal: Lancet Oncol Date: 2015-05-13 Impact factor: 41.316

1. Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.

Authors: Meisong Ding; William Zollinger; Robert Ebeling; David Heard; Ryan Posey
Journal: J Appl Clin Med Phys Date: 2018-09-14 Impact factor: 2.102

1 in total